Literature DB >> 32355690

Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?

Giovanni Targher1.   

Abstract

Entities:  

Year:  2020        PMID： 32355690      PMCID： PMC7188532          DOI： 10.21037/hbsn.2019.10.21

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  16 in total

1.  Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Stefano Rodella; Roberto Tessari; Luciano Zenari; Christopher Day; Guido Arcaro
Journal:  Diabetes Care       Date:  2007-02-02       Impact factor: 19.112

2.  Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults.

Authors:  Christopher D Byrne; Janisha Patel; Eleonora Scorletti; Giovanni Targher
Journal:  BMJ       Date:  2018-07-12

Review 3.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

4.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  J Hepatol       Date:  2016-04-07       Impact factor: 25.083

Review 5.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

Review 6.  Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.

Authors:  Fernando Bril; Kenneth Cusi
Journal:  Diabetes Care       Date:  2017-03       Impact factor: 19.112

7.  The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Zobair M Younossi; Pegah Golabi; Leyla de Avila; James Minhui Paik; Manirath Srishord; Natsu Fukui; Ying Qiu; Leah Burns; Arian Afendy; Fatema Nader
Journal:  J Hepatol       Date:  2019-07-04       Impact factor: 25.083

Review 8.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-15       Impact factor: 11.382

9.  Mortality from chronic liver diseases in diabetes.

Authors:  Giacomo Zoppini; Ugo Fedeli; Nicola Gennaro; Mario Saugo; Giovanni Targher; Enzo Bonora
Journal:  Am J Gastroenterol       Date:  2014-06-03       Impact factor: 10.864

Review 10.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425
View more
  3 in total

1.  Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors.

Authors:  Shaista Kanwal; Tahir Ghaffar; Azizul Hasan Aamir; Khalid Usman
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

2.  Protective Role of Loranthus regularis against Liver Dysfunction, Inflammation, and Oxidative Stress in Streptozotocin Diabetic Rat Model.

Authors:  Ahmed Z Alanazi; Faleh Alqahtani; Ramzi A A Mothana; Mohamed Mohany; Hatem M Abuohashish; Mohammed M Ahmed; Salim S Al-Rejaie
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-10       Impact factor: 2.629

3.  Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver.

Authors:  Lisha Chen; Li Jiang
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.